Author Policies

1. Open Access Policy
The Open Access (OA) policy for the Diabetes Research – Open Journal ensures that all published research is freely accessible to the global research community without paywalls or subscription fees. This policy aligns with the journal's mission to promote the wide dissemination of high-quality research, enabling academics, healthcare professionals, and practitioners to access the latest findings and treatments. Authors retain copyright over their work and grant the journal a license to publish and distribute their articles under a Creative Commons license, such as CC BY, allowing others to reuse and adapt the research while providing proper attribution. By adopting the OA model, the journal fosters transparency, collaboration, and the rapid sharing of innovations in diabetes research. Open access is especially critical in healthcare, as it accelerates the adoption of new findings and interventions that can directly improve patient outcomes.

2. Plagiarism Policy
The plagiarism policy of the Diabetes Research – Open Journal ensures that all published content is original, and that proper credit is given to the work of others. Authors are required to submit manuscripts that represent their own original research and to appropriately cite all references, including prior research, methodologies, and clinical data. The journal uses plagiarism detection software, such as Turnitin, to screen submissions for any potential instances of plagiarism or self-plagiarism. If any form of plagiarism is detected, the manuscript may be rejected, or an investigation may be launched. This policy ensures academic integrity and upholds the credibility of the journal. Authors found guilty of plagiarism may face retraction of their published work and a ban on future submissions. The goal is to maintain a high standard of scholarship and to foster a culture of honesty and transparency in the diabetes research field.

3. Copyright Policy
The copyright policy outlines the intellectual property rights associated with articles published in the journal. Authors generally retain copyright to their work upon publication, but they grant the journal a license to distribute, display, and share the work under open-access terms. Many journals in healthcare and medical research encourage authors to select a Creative Commons license, such as CC BY, which allows the broader community to reuse and remix the work, provided proper attribution is given to the original author. This open-access model promotes the free exchange of ideas, fosters collaboration, and ensures that advancements in diabetes research can be easily accessed and applied across healthcare sectors. Authors also retain the right to reuse their own work in other academic or professional contexts, such as in books or conference presentations. The copyright policy ensures clarity regarding the usage rights of published material while respecting the authors' intellectual contributions.

4. Rights and Grants to the Author
The "Rights and Grants to the Author" policy establishes the rights that authors retain after their work is published in the journal. Authors typically retain ownership of their article and the right to reuse the content for academic purposes, such as in future publications, presentations, or books. However, by submitting to the journal, authors grant the journal an exclusive or non-exclusive license to publish, distribute, and reproduce their work in all formats (print, digital, etc.). Authors are also encouraged to deposit their work in institutional repositories or personal websites, as long as proper attribution is maintained. This policy ensures that research can be widely disseminated while protecting the author's intellectual property and allowing for reuse and further research in the field of diabetes.

5. Licensing Policy
The licensing policy defines how the journal allows others to use, share, and reuse published work. For medical and healthcare journals, the most common licenses are those provided by Creative Commons (CC), such as the CC BY license, which allows anyone to reuse, remix, and redistribute the work as long as they give appropriate credit to the original author. The policy encourages authors to select open licenses to maximize the accessibility and utility of their research. The licensing policy is important because it allows the journal to legally distribute the work, ensures authors maintain recognition of their intellectual property, and promotes the wide dissemination of diabetes research. The journal also ensures that all third-party content, such as data, images, and figures, is used with the appropriate permissions.

6. APC Waiver Policy
The Article Processing Charge (APC) Waiver Policy outlines the circumstances under which authors can receive a waiver or reduction in the publication fee, which is typically required for open-access articles. The APC covers the costs of peer review, editing, and publishing. The waiver policy is designed to ensure that authors from underrepresented or financially constrained backgrounds can still publish their research in the journal. Eligibility for an APC waiver might be based on factors such as the author's geographical location (e.g., authors from low-income countries), institutional support, or early-career status. This policy helps promote inclusivity in the academic publishing process and ensures that important research on diabetes can be shared widely without financial barriers.

7. Withdrawal Policy
The manuscript withdrawal policy provides the terms under which authors can retract or withdraw their submission after it has been submitted but before it is formally accepted or published. Common reasons for withdrawal include finding a significant error in the manuscript, choosing to submit the paper to another journal, or deciding to update the research. The policy outlines the process for withdrawing a manuscript, including notifying the editorial office, confirming that all co-authors agree with the decision, and ensuring that the manuscript is not cited or referenced once withdrawn. The policy also establishes guidelines for handling withdrawn papers that have already gone through peer review. This ensures the journal maintains its credibility and avoids confusion in the academic record.

8. Human and Animal Rights Policy
The Human and Animal Rights policy ensures that all research involving human or animal subjects adheres to ethical standards and legal requirements. Authors must confirm that their studies comply with the ethical guidelines of the Declaration of Helsinki for human participants and adhere to relevant laws and regulations for animal studies. Institutional review board (IRB) or ethics committee approval must be obtained before starting any study involving humans or animals. This policy applies to research on human-centered design, medical devices, or clinical trials in diabetes treatment. The policy protects the rights and welfare of participants and ensures that the research is conducted ethically, providing confidence to the academic community and the public.

9. Errata, Retractions, and Corrigenda Policy
The errata, retraction, and corrigenda policy outlines the procedures for addressing published errors or misconduct. An erratum is issued for minor corrections, such as typographical errors, while a corrigendum is used for more significant but non-substantial mistakes, such as incorrect equations or data. A retraction occurs when a study is found to have major ethical issues, such as falsification of data or plagiarism, and is no longer considered valid. This policy ensures that errors in the academic record are corrected and that any issues related to a study’s validity are transparently addressed. This maintains the integrity of diabetes research and ensures that the journal's content remains trustworthy.

10. Digital Preservation
The digital preservation policy ensures that published articles remain accessible long after they have been published. The journal works with trusted digital repositories and preservation organizations to ensure that articles are securely archived, making them accessible for future researchers. By participating in services such as LOCKSS (Lots of Copies Keep Stuff Safe) or Portico, the journal safeguards against data loss from server failures or obsolescence of file formats. This policy is critical to maintaining access to valuable research in the long term, ensuring that studies on diabetes are available for ongoing reference and use by researchers, healthcare professionals, and policymakers.

11. Participant/Patient Privacy and Informed Consent
Research published in the journal involving human participants must adhere to strict guidelines for privacy, confidentiality, and informed consent. Authors must ensure that participants’ personal information is protected and that informed consent has been obtained before data collection. This policy complies with international ethical standards and regulatory requirements, such as HIPAA (Health Insurance Portability and Accountability Act) for patient privacy in the U.S., and the EU’s GDPR (General Data Protection Regulation). It ensures that participants are aware of their rights and that their data is used responsibly and ethically in diabetes research.

12. Data Sharing Policy
The data sharing policy encourages authors to share the data supporting their published findings in a public repository whenever possible. Data sharing fosters transparency, reproducibility, and the advancement of science. For clinical trials or large datasets in diabetes research, sharing raw data, statistical analysis, and protocols allows other researchers to verify and build upon the work. Authors should make data available unless it compromises participant privacy or proprietary interests. This policy is crucial for accelerating discoveries in diabetes care and treatment, helping to create a collaborative environment for future research.

13. Submission of Manuscript
The submission process for the journal requires authors to submit their manuscripts via the online submission system. Before submission, authors must ensure that their manuscript adheres to the journal's guidelines for formatting, referencing, and ethical considerations. The submission must include a cover letter, an abstract, keywords, and all relevant sections of the manuscript (e.g., methods, results, and conclusion). Authors should also disclose any conflicts of interest related to their research. Once submitted, manuscripts undergo peer review before a decision on acceptance is made.

14. Manuscript Preparation
Authors must follow the journal’s specific guidelines when preparing their manuscript for submission. The manuscript should be typed in a clear and readable font, typically Times New Roman, 12-point size, and formatted with double-spacing. References should be cited according to the journal's referencing style (e.g., APA or Vancouver). Figures and tables must be submitted in the appropriate formats, with high resolution for clarity. Manuscripts should also include an introduction, materials and methods, results, discussion, and conclusion section, providing a comprehensive overview of the research and its implications for diabetes research.

15. Check List
Before submitting, authors must ensure their manuscript includes all required components, such as: 1) A cover letter, 2) Abstract and keywords, 3) Properly formatted references, 4) Consent for publication if necessary, 5) Acknowledgment of conflicts of interest, and 6) Compliance with ethical standards. The checklist helps authors ensure they have met all submission requirements and that their manuscript is ready for review.

16. Sample Paper
A sample paper is available for authors to download to guide them in preparing their manuscript according to the journal's formatting and content requirements. The sample paper provides a practical template that demonstrates the proper organization and citation style. Authors are encouraged to refer to the sample paper as they prepare their own submissions to streamline the process.

17. Article Processing Charge
Authors whose papers are accepted for publication will be required to pay an Article Processing Charge (APC) to cover the costs associated with peer review, editing, and publication. The APC ensures that the journal remains open-access and free of charge for readers. Authors should confirm their ability to cover the APC at the time of submission. Discounts or waivers may be available based on the author’s financial situation or institutional support.

18. Author’s Agreement Form
Before publication, authors are required to sign an agreement form, confirming that they hold the rights to their work and that it complies with the journal's policies. The form also ensures that the authors grant the journal the necessary permissions to publish, distribute, and license the work under the chosen Creative Commons license. The form helps clarify ownership, copyright, and licensing matters.

19. English Language Editing
For non-native English-speaking authors, the journal offers the option to have their manuscript professionally edited for clarity and correctness in English. This ensures that the manuscript meets the journal's linguistic standards and enhances its chances for acceptance. The editing service focuses on grammar, syntax, punctuation, and clarity, without altering the research content.

20. Complaints Policy
The complaints policy provides a framework for addressing any grievances related to the editorial or publishing process. If an author, reviewer, or reader has a complaint regarding the content, peer review process, or editorial decisions, they may submit their concerns in writing to the editorial office. The journal will investigate the complaint, address it according to the policy, and provide a response in a timely manner. This policy ensures that issues are handled professionally and that the integrity of the journal is maintained.

Author Policies

Current Issue

Information